Gene variants protect against relapse after treatment for Hepatitis C
Researchers at the Sahlgrenska Academy have identified a gene, which explains why certain patients with chronic hepatitis C do not experience relapse after treatment. The discovery may contribute to more effective treatment. More than 100 million humans around the world are infected with hepatitis C virus. The infection gives rise to chronic liver inflammation, which […]
